Keywords: bayer, curagen, deal, worth, up, billion, over

Bayer and CuraGen in R&D deal worth up to $1.5 billion over 15 years

Article | 17 January 2001

Print This

German pharmaceuticals and chemicals group Bayer has linked up withCuraGen of the USA in a genomics R&D partnership which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in